Founders Fund — 2016 Investments
5 investments dated 2016 · listed companies and verified rows first · show all
BiotechNorth Chicago, US
Thomas A. Hurwich(Executive Officer)Timothy J. Richmond(Executive Officer)Henry Gosebruch(Executive Officer)Azita Saleki-Gerhardt(Executive Officer)Michael E. Severino(Executive Officer)William Chase(Executive Officer)
Co-investorsArtis Ventures
8i develops virtual and augmented reality technologies for human connection and immersive experiences, serving audiences across entertainment, education, training, and professional settings.
AI & Machine LearningDeep TechMedia & EntertainmentLos Angeles, US
Lincoln Gasking(Executive Officer, Director)Hayes Mackaman(CEO)
BoardJames D Robinson(Director)Scott Levine(Director)
Board seatScott Nolan· per SEC Form D · $22.5M raise · filed Nov 2016
Co-investorsAdvancit CapitalRight Click CapitalRRE VenturesSamsung Next
Walnut, US
Eric Ries(Executive Officer, Director, Promoter)
BoardJohn V Bautista(Director)
Board seatBrian Singerman· per SEC Form D · $103.4M raise · filed Aug 2022
Synthego develops CRISPR gene-editing and molecular diagnostics products, including custom CRISPR editors in mRNA or protein formats, base editors, and cell-free protein and RNA production systems.
BiotechDeep TechHealthtechMedical DevicesRedwood City, US
Paul John Dabrowski(Executive Officer, Director)Michael Jakub Dabrowski(Executive Officer, Director)
BoardDrew Oetting(Director)in
Board seatScott Nolan· per SEC Form D
Co-investorsAAF Management Ltd.AME Cloud VenturesDeclaration PartnersKhosla VenturesMenlo VenturesOpen Field Capital+6 more
Moffett Field, US
ROBERT RICHARDS(Executive Officer, Director)NAVEEN JAIN(Director)BARNEY PELL(Director)DAVEN MAHARAJ(Executive Officer)ANDREW ALDRIN(Executive Officer)
Co-investorsCollaborative Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.